BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16300990)

  • 1. Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone.
    Kessler-Icekson G; Schlesinger H; Freimann S; Kessler E
    Int J Biochem Cell Biol; 2006 Mar; 38(3):358-65. PubMed ID: 16300990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for co-regulation with type I collagen.
    Shalitin N; Schlesinger H; Levy MJ; Kessler E; Kessler-Icekson G
    J Cell Biochem; 2003 Oct; 90(2):397-407. PubMed ID: 14505355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen remodeling after myocardial infarction in the rat heart.
    Cleutjens JP; Verluyten MJ; Smiths JF; Daemen MJ
    Am J Pathol; 1995 Aug; 147(2):325-38. PubMed ID: 7639329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats.
    Lal A; Veinot JP; Leenen FH
    Cardiovasc Res; 2004 Dec; 64(3):437-47. PubMed ID: 15537497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
    Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen.
    Lal A; Veinot JP; Ganten D; Leenen FH
    J Mol Cell Cardiol; 2005 Sep; 39(3):521-9. PubMed ID: 15950985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
    Mori T; Kurumazuka D; Matsumoto C; Shirakawa H; Kimura S; Kitada K; Kobayashi K; Matsuda H; Hayashi T; Kitaura Y; Matsumura Y
    Eur J Pharmacol; 2009 Nov; 623(1-3):84-8. PubMed ID: 19766104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of collagen type I gene expression in the ventricular myocardium of thyroidectomized male and female rats.
    Klein LE; Sigel AV; Douglas JA; Eghbali-Webb M
    J Mol Cell Cardiol; 1996 Jan; 28(1):33-42. PubMed ID: 8745212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
    Geng DF; Wu W; Jin DM; Wang JF; Wu YM
    Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cardiac fibrosis by aldosterone.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
    Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
    Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling.
    Bryant JE; Shamhart PE; Luther DJ; Olson ER; Koshy JC; Costic DJ; Mohile MV; Dockry M; Doane KJ; Meszaros JG
    J Mol Cell Cardiol; 2009 Feb; 46(2):186-92. PubMed ID: 19041328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction.
    Zhang YL; Zhou SX; Lei J; Yuan GY; Wang JF
    Chin Med J (Engl); 2008 Nov; 121(21):2192-6. PubMed ID: 19080183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure.
    Nehme JA; Lacolley P; Labat C; Challande P; Robidel E; Perret C; Leenhardt A; Safar ME; Delcayre C; Milliez P
    J Mol Cell Cardiol; 2005 Sep; 39(3):511-9. PubMed ID: 15992819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
    Pantos C; Mourouzis I; Markakis K; Dimopoulos A; Xinaris C; Kokkinos AD; Panagiotou M; Cokkinos DV
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):333-9. PubMed ID: 17560116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
    Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
    Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.